These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1386 related articles for article (PubMed ID: 11287630)
21. Assessment of cell-signaling pathways in the regulation of mammalian target of rapamycin (mTOR) by amino acids in rat adipocytes. Pham PT; Heydrick SJ; Fox HL; Kimball SR; Jefferson LS; Lynch CJ J Cell Biochem; 2000 Sep; 79(3):427-41. PubMed ID: 10972980 [TBL] [Abstract][Full Text] [Related]
23. Phosphorylation of human insulin receptor substrate-1 at Serine 629 plays a positive role in insulin signaling. Luo M; Langlais P; Yi Z; Lefort N; De Filippis EA; Hwang H; Christ-Roberts CY; Mandarino LJ Endocrinology; 2007 Oct; 148(10):4895-905. PubMed ID: 17640984 [TBL] [Abstract][Full Text] [Related]
24. Effects of streptozocin diabetes and diabetes treatment by islet transplantation on in vivo insulin signaling in rat heart. Laviola L; Belsanti G; Davalli AM; Napoli R; Perrini S; Weir GC; Giorgino R; Giorgino F Diabetes; 2001 Dec; 50(12):2709-20. PubMed ID: 11723053 [TBL] [Abstract][Full Text] [Related]
25. Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade. Shi Y; Yan H; Frost P; Gera J; Lichtenstein A Mol Cancer Ther; 2005 Oct; 4(10):1533-40. PubMed ID: 16227402 [TBL] [Abstract][Full Text] [Related]
26. Modulation of insulin receptor substrate-1 tyrosine phosphorylation by an Akt/phosphatidylinositol 3-kinase pathway. Li J; DeFea K; Roth RA J Biol Chem; 1999 Apr; 274(14):9351-6. PubMed ID: 10092613 [TBL] [Abstract][Full Text] [Related]
27. Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 3-kinase/AKT pathway. del Rincón SV; Rousseau C; Samanta R; Miller WH Oncogene; 2003 May; 22(22):3353-60. PubMed ID: 12776186 [TBL] [Abstract][Full Text] [Related]
28. Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes. Ishibashi KI; Imamura T; Sharma PM; Huang J; Ugi S; Olefsky JM J Clin Invest; 2001 May; 107(9):1193-202. PubMed ID: 11342583 [TBL] [Abstract][Full Text] [Related]
29. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Sekulić A; Hudson CC; Homme JL; Yin P; Otterness DM; Karnitz LM; Abraham RT Cancer Res; 2000 Jul; 60(13):3504-13. PubMed ID: 10910062 [TBL] [Abstract][Full Text] [Related]
30. Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes. Fasshauer M; Klein J; Kriauciunas KM; Ueki K; Benito M; Kahn CR Mol Cell Biol; 2001 Jan; 21(1):319-29. PubMed ID: 11113206 [TBL] [Abstract][Full Text] [Related]
31. A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. Haruta T; Uno T; Kawahara J; Takano A; Egawa K; Sharma PM; Olefsky JM; Kobayashi M Mol Endocrinol; 2000 Jun; 14(6):783-94. PubMed ID: 10847581 [TBL] [Abstract][Full Text] [Related]
32. PKCdelta and mTOR interact to regulate stress and IGF-I induced IRS-1 Ser312 phosphorylation in breast cancer cells. Mingo-Sion AM; Ferguson HA; Koller E; Reyland ME; Van Den Berg CL Breast Cancer Res Treat; 2005 Jun; 91(3):259-69. PubMed ID: 15952059 [TBL] [Abstract][Full Text] [Related]
33. Involvement of Raf-1 kinase and protein kinase C zeta in insulin-like growth factor I-induced brown adipocyte mitogenic signaling cascades: inhibition by cyclic adenosine 3',5'-monophosphate. Valverde AM; Teruel T; Lorenzo M; Benito M Endocrinology; 1996 Sep; 137(9):3832-41. PubMed ID: 8756554 [TBL] [Abstract][Full Text] [Related]
34. Regulation of insulin/insulin-like growth factor-1 signaling by proteasome-mediated degradation of insulin receptor substrate-2. Rui L; Fisher TL; Thomas J; White MF J Biol Chem; 2001 Oct; 276(43):40362-7. PubMed ID: 11546773 [TBL] [Abstract][Full Text] [Related]
35. Regulation of IRS-1/SHP2 interaction and AKT phosphorylation in animal models of insulin resistance. Lima MH; Ueno M; Thirone AC; Rocha EM; Carvalho CR; Saad MJ Endocrine; 2002 Jun; 18(1):1-12. PubMed ID: 12166618 [TBL] [Abstract][Full Text] [Related]
36. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Zhong H; Chiles K; Feldser D; Laughner E; Hanrahan C; Georgescu MM; Simons JW; Semenza GL Cancer Res; 2000 Mar; 60(6):1541-5. PubMed ID: 10749120 [TBL] [Abstract][Full Text] [Related]
37. Muscle damage impairs insulin stimulation of IRS-1, PI 3-kinase, and Akt-kinase in human skeletal muscle. Del Aguila LF; Krishnan RK; Ulbrecht JS; Farrell PA; Correll PH; Lang CH; Zierath JR; Kirwan JP Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E206-12. PubMed ID: 10893341 [TBL] [Abstract][Full Text] [Related]
38. Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779. Shi Y; Gera J; Hu L; Hsu JH; Bookstein R; Li W; Lichtenstein A Cancer Res; 2002 Sep; 62(17):5027-34. PubMed ID: 12208757 [TBL] [Abstract][Full Text] [Related]
39. Mono- or dual-phosphorylation of akt kinase is regulated by distinct receptors that involve the common insulin receptor substrate. Schnyder B; Lahm H; Pittet M; Schnyder-Candrian S J Recept Signal Transduct Res; 2002; 22(1-4):213-28. PubMed ID: 12503617 [TBL] [Abstract][Full Text] [Related]